Suppr超能文献

患有囊性子宫内膜增生-子宫积脓综合征的母犬的肾生物标志物、临床参数和肾多普勒流速测定。

Renal biomarkers, clinical parameters, and renal Doppler velocimetry in bitches with cystic endometrial hyperplasia-pyometra complex.

机构信息

Laboratório de Andrologia e Reprodução Animal Assistida - LARAA, Londrina, Brazil.

Botupharma®, Botucatu, Brazil.

出版信息

Reprod Domest Anim. 2024 Jan;59(1):e14518. doi: 10.1111/rda.14518.

Abstract

Cystic endometrial hyperplasia (CEH)-pyometra complex is the most common uterine infection in adult and elderly bitches and can cause renal dysfunction. The aim of this study was to measure and compare urinary creatinine, urea, symmetric dimethylarginine (SDMA), urinary protein-creatinine ratio (UPC), measurement of systolic blood pressure (SBP), and Doppler velocimetry of renal arteries in patients with CEH-pyometra complex before and after an average of 6 months of treatment, evaluating the possibility of the changes persisting. The evaluation was conducted at two moments: M1 (at the diagnosis of CEH-pyometra, n = 36) and M2 (after an average of six months of treatment, n = 16). For the control group, eight bitches with no changes in blood tests or history of conditions underwent Doppler ultrasound evaluation of the renal arteries. At both M1 and M2, we measured creatinine, urea, and serum SDMA, UPC, SBP, and Doppler ultrasound of the renal arteries. Patients were evaluated according to the following groups: azotemic (AZO) and non-azotemic (NAZO), and open and closed cervix pyometra. The parameters were compared between animals present in both moments presented as M1R (bitches that were in M1 and M2) and M2. Statistical significance was considered when p < .05. The medians found for creatinine in M1 were as follows: 1.15 mg/dL, being 1.8 mg/dL for AZO (12/36) and 0.95 mg/dL for NAZO (24/36); and in M2: 0.85 mg/dL (16/16), being 1.15 mg/dL for AZO (4/16) and 0.8 mg/dL for NAZO (12/36). For urea, in M1 it was 36 mg/dL (32/36), with AZO being 103 mg/dL (11/32) and 33 mg/dL in NAZO (21/32); and in M2 32 mg/dL (16/ 16), being 29 mg/dL for AZO (4/36), and 31 mg/dL for NAZO (3/15). The median SDMA measured in M1R was 17 μg/dL (15/16), with AZO being 31 μg/dL (3/15), and NAZO being 16.5 μg/dL (12/15); and in M2, SDMA was 12 μg/dL (16/16), with AZO being 12.5 μg/dL (4/16), and NAZO being 12 μg/dL (12/16). The median UPC measured in M1 was 1.15 (10/36), with AZO being 0.25 (1/10), and NAZO being 1.38 (9/10); and in M2, it was 0.2 (13/16), being 0.1 in AZO (4/13), and 0.2 (9/16) in NAZO. For SBP, in M1, it was 118 mmHg (30/36), with AZO being 102 mmHg (10/30) and 133 mmHg in NAZO (20/30); and in M2 142.5 mmHg (12/16), being 155 mmHg for AZO (4/12), and 140 mg/dL for NAZO (8/12). When comparing animals with open and closed cervixes, a difference was found between SDMA measurements (p = .001). There was a distinction between PI and RI of the left and right kidneys consecutively (p = .007; p = .033; p = .019; p = .041). Correlations found in M1: SDMA × PI RIM DIR (r = 0.873; p = .002), SDMA × PSV RIM ESQ (r = 0.840; p = .004), SDMA × EDV RIM ESQ (r = 0.675; p = .046). With this study, we conclude a return to normality of renal biomarkers and clinical parameters after six months. Yet, there is a persistence of Doppler velocimetric measurements between the two moments. Thus, this parameter is not suitable for identifying and classifying chronic kidney injury in bitches with pyometra.

摘要

囊性子宫内膜增生 (CEH)-子宫蓄脓综合征是成年和老年母犬中最常见的子宫感染,可导致肾功能障碍。本研究的目的是测量和比较患有 CEH-子宫蓄脓综合征的犬在平均 6 个月的治疗前后的尿液肌酐、尿素、对称二甲基精氨酸 (SDMA)、尿蛋白肌酐比 (UPC)、收缩压 (SBP) 和肾动脉多普勒速度,并评估这些变化是否持续。该评估在两个时间点进行:M1(诊断 CEH-子宫蓄脓时,n=36)和 M2(平均治疗 6 个月后,n=16)。对于对照组,8 只未出现血液检查或病史变化的犬进行了肾动脉多普勒超声评估。在 M1 和 M2 时,我们测量了肌酐、尿素和血清 SDMA、UPC、SBP 和肾动脉的多普勒超声。根据以下组评估患者:氮血症 (AZO) 和非氮血症 (NAZO),以及宫颈开放和闭合的子宫蓄脓。将 M1R 中存在的动物(M1 和 M2 均存在的动物)和 M2 之间的参数进行比较。当 p<.05 时,认为具有统计学意义。M1 时发现的肌酐中位数如下:1.15mg/dL,AZO 为 1.8mg/dL(36/36),NAZO 为 0.95mg/dL(24/36);M2 时为 0.85mg/dL(16/16),AZO 为 1.15mg/dL(4/16),NAZO 为 0.8mg/dL(12/36)。M1 时的尿素中位数为 36mg/dL(32/36),AZO 为 103mg/dL(11/32),NAZO 为 33mg/dL(21/32);M2 时为 32mg/dL(16/16),AZO 为 29mg/dL(4/36),NAZO 为 31mg/dL(3/15)。M1R 中测量的 SDMA 中位数为 17μg/dL(15/16),AZO 为 31μg/dL(3/15),NAZO 为 16.5μg/dL(12/15);M2 时为 12μg/dL(16/16),AZO 为 12.5μg/dL(4/16),NAZO 为 12μg/dL(12/16)。M1 时测量的 UPC 中位数为 1.15(10/36),AZO 为 0.25(1/10),NAZO 为 1.38(9/10);M2 时为 0.2(13/16),AZO 为 0.1(4/13),NAZO 为 0.2(9/16)。M1 时 SBP 中位数为 118mmHg(30/36),AZO 为 102mmHg(10/30),NAZO 为 133mmHg(20/30);M2 时为 142.5mmHg(12/16),AZO 为 155mmHg(4/12),NAZO 为 140mmHg/dL(8/12)。当比较宫颈开放和闭合的动物时,SDMA 测量值存在差异(p=0.001)。左、右肾的 PI 和 RI 连续存在差异(p=0.007;p=0.033;p=0.019;p=0.041)。M1 时的相关性:SDMA×PI RIM DIR(r=0.873;p=0.002),SDMA×PSV RIM ESQ(r=0.840;p=0.004),SDMA×EDV RIM ESQ(r=0.675;p=0.046)。通过这项研究,我们得出结论,经过 6 个月的治疗后,肾生物标志物和临床参数恢复正常。然而,在这两个时间点之间,仍然存在多普勒速度测量值的持续存在。因此,该参数不适合识别和分类患有子宫蓄脓的犬的慢性肾脏损伤。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验